MétaCan
Menu
Back to cohort
Record W4400624370 · doi:10.3329/bccj.v11i2.69187

Role of Nigella Sativa (Black Cumin Seeds) as an Adjunct Therapy in Treating Severe and Critical COVID -19 Infection Compared to Those with Standard Therapy: An Open Label Randomized Clinical Trial

2023· article· en· W4400624370 on OpenAlexaff
Mohammad Omar Faruq, Amina Sultana, Umme Kulsum Chy, Karishma Shamarukh, Chowdhury Tasneem Hasin, Mohammed Salah Uddin, Samira Humaira Habib, Susmita Hossain Natasha, Tamanna Yasmin Shena, Tasmia Kashfi, Md Gisan Hossain, Md Sakib Khan, Syed Mustajab Hasan, MD Saifuddin Sujhon, Mehnaz Ferdous, Syed Mahfuzur Rahman, Ahmed Sayeed Arefin, Mir Atiqur Rahman, Shamsi Islam Orin

Bibliographic record

VenueBangladesh Critical Care Journal · 2023
Typearticle
Languageen
FieldMedicine
TopicNigella sativa pharmacological applications
Canadian institutionsCentre for Global Health Research
Fundersnot available
KeywordsMedicineRandomized controlled trialMechanical ventilationCoronavirus disease 2019 (COVID-19)Nigella sativaClinical trialIntensive care unitInternal medicineAnesthesiaTraditional medicine

Abstract

fetched live from OpenAlex

Background: During recent COVID-19 pandemic (2019-2021) clinician-researchers had been looking for effective treatment of Covid-19 infection. Nigella sativa (NS), a well-known herbal medicine, has beenused asanti-viral, anti-inflammatory, immune modulatory, anti-oxidant, broncho-dilatory, anti-histaminic, anti-tussive activitiesfor patients with mild to moderate COVID-19 infection. Our study aimed to determine the efficacy of NS for treatment of severe and critically ill Covid-19 patients as an adjunct therapy with conventional treatment. Method: This wasan open label randomized clinical trial conducted in severely and critically ill COVID-19 patients admitted into COVID ICU of United Hospital, Dhaka, Bangladesh. The study subjects were randomly divided into two equal groups: NS group in which subjects received NS orally in addition to the conventional treatment, and Control group, who received conventional treatment only. Primary outcome focused mainly on duration of ICU stay, use of mechanical ventilation (MV)/noninvasive ventilation (NIV)/ High-flow nasal cannula (HFNC) oxygen (HFNO) and mortality. The secondary outcomes were based on comparison of those above mentioned parameters between the groups (NS and Control). Results: A total of 150 subjects were enrolled according to eligibility criteria.There were 60 deaths (29 NS + 31 Cont.) and 90 survivals (46 NS + 44 Cont.). Among the survivals 16 NS subjects as opposed to 6 Cont. subjects stayed in ICU for 8 to 14 days (P = 0.043). Twenty one subjects of NS group as opposed to 8 subjects of Cont. group stayed in ICU for less than 7 days to 14 days. Whereas among subjects who died there was no significant difference in length of stay among majority of NS and Cont. subjects. NS group required significantly lower number of O2 delivery methods likemechanical ventilation (MV), noninvasive ventilation (NIV),High-flow nasal oxygen (HFNO) compared to their counterparts on Day 7 and Day 14 of stay in ICU. Conclusion: NS as an adjunct therapy with severe and critical COVID 19 infection was associated with some reduction of duration of stay in ICU but significantly less requirement of invasive and non-invasive ventilator support, high flow nasal oxygen than standard treatment group. Establishing accurately therapeutic efficacy of NS in critically ill COVID-19 patients requires placebo controlled double blind studies. Bangladesh Crit Care J September 2023; 11 (2): 75-82

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.006
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.035
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0040.006
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.001
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.135
GPT teacher head0.485
Teacher spread0.350 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueBangladesh Critical Care JournalSame topicNigella sativa pharmacological applicationsFrench-language works237,207